Foresite Capital vs OrbiMed
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| Foresite Capital | OrbiMed | |
|---|---|---|
| Type | Venture capital | Venture capital |
| HQ | Larkspur | New York |
| Founded | 2011 | 1999 |
| Check size | — | $1M – $75M |
| Stages | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices | Biotech, Digital Health, Healthtech, Longevity, Medical Devices |
| AUM | $3.2B | $20.6B |
| Tracked investments | 186 | 205 |
| Exits (acquired/public) | 1 | — |
| Dated deals, last 24 mo | 4 | 5 |
Shared portfolio · 11
Adicet BioAlumisArriVent BioPharmaAura BiosciencesCandid TherapeuticsCompass TherapeuticsDelfi DiagnosticsDisc MedicineInsmedOdyssey TherapeuticsRayThera
Frequently asked questions
- Do Foresite Capital and OrbiMed invest together?
- Yes — Foresite Capital and OrbiMed appear together in 11 tracked portfolio companies, including Adicet Bio, Alumis, ArriVent BioPharma, Aura Biosciences, Candid Therapeutics.